UroGen Pharma
URGN
URGN
83 hedge funds and large institutions have $124M invested in UroGen Pharma in 2022 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 22 increasing their positions, 22 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
12% less capital invested
Capital invested by funds: $140M → $124M (-$16.4M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $4K
Holders
83
Holding in Top 10
–
Calls
–
Puts
$4K
Top Buyers
| 1 | +$2.34M | |
| 2 | +$1.28M | |
| 3 | +$779K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$758K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$724K |
Top Sellers
| 1 | -$3.6M | |
| 2 | -$2.26M | |
| 3 | -$314K | |
| 4 |
BlackRock
New York
|
-$238K |
| 5 |
Barclays
London,
United Kingdom
|
-$180K |